This finding pinpointed an altered dynamic of incretin secretion in PCOS that might contribute to the risk of type 2 diabetes [46]
Organizations must evaluate clinical value, financial impact, compliance requirements, and workforce expectations when determining coverage strategies
Chem Biol Interact, 1998
Common ICD-10-CM Codes Type 2 Diabetes E11.9 Type 2 diabetes mellitus without complications E11.65 Type 2 diabetes mellitus with hyperglycemia E11.8 Type 2 diabetes mellitus with unspecified complications Obesity / Weight Management E66.9 Obesity, unspecified E66.01 Morbid (severe) obesity due to excess calories Z68.30Z68.45 BMI codes (required by many payers) Prediabetes (often not covered for GLP-1) R73.03 Prediabetes Key Coding Tip Most payers cover GLP-1 medications only for FDA-approved indications
Peptide YY (PYY) PYY is co-secreted from the intestinal L cells together with GLP-1 following food intake
GLP-1 drugs slow down the emptying of the stomach, so as a result, people feel fuller and ultimately eat less, says Robert Gabbay, MD, PhD, chief scientific and medical officer with the American Diabetes Association